Abstract:AIM: To clone flagellin genes A (flaA) and B (flaB) from a clinical strain of Helicobacter pylori(Hpylori) and to construct prokaryotic expression systems of the genes and identify immunity of the fusion proteins.METHODS: The flaA and flaB genes from a clinical Hpylori isolate Y06 were amplified by high fidelity PCR. The nucleotide sequences of target DNA amplification fragments from the two genes were sequenced after T-A cloning. The recombinant expression vector pET32a inserted with flaA and flaB genes was constructed, respectively. The expressions of FlaA and FlaB fusion proteins in E. coli BL21DE3 induced by isopropylthio-p-D-galactoside (IPTG) at different concentrations were examined by SIDS-PAGE. Western blot using commercial antibodies against whole cell of H pylori and immunodiffusion assay using self-prepared rabbit antiserum against FlaA (rFlaA) or FlaB (rFlaB) recombinant proteins were applied to the determination of the fusion proteins immunity. ELISA was used to detect the antibodies against rFlaA and rFlaB in sera of 125 Hpylori infected patients and to examine rFlaA and rFlaB expression in 98 clinical isolates of H pylori, respectively.RESULTS: In comparison with the reported corresponding sequences, the nucleotide sequence homologies of the cloned flaA and flaB genes were from 96.28-97.13% and 96.31-97.73%, and their putative amino acid sequence homologies were 99.61-99.80% and 99.41-100% for the two genes, respectively. The output of rFlaA and rFlaB expressed by pET32a-flaA-BL21DE3 and pET32J-flaB-BL21DE3 systems was as high as 40-50% of the total bacterial proteins. Both rFlaA and rFlaB were able to combine with the commercial antibodies against whole cell of Hpylori and to induce rabbits to produce specific antibodies with the same 1:2 immunodiffusion titers after the animals were immunized with the two recombinant proteins. Ninety-eight and zero point 4 and 92.80% of the serum samples from 125 patients infected with Hpylori were positive for rFlaA and rFlaB antibodies, respectively. One hundred percent and 98.98% of the 98 tested isolates of H pylori were detectable for rFlaA and rFlaB epitopes, respectively.CONCLUSION: Two prokaryotic expression systems with high efficiency of H pylori flaA and flaB genes were successfully established. The expressed rFlaA and rFlaB showed satisfactory immunoreactivity and antigenicity. High frequencies of FlaA and FlaB expression in different Hpylori clinical strains and the general existence of specific antibodies against FlaA and FlaB in Hpylori infected patients strongly indicate that FlaA and FlaB are excellent antigen candidates for developing H pylori vaccine.

[Expression and Immunogenicity Analysis of a Recombinant Fusion Protein of V. Cholera Ctb and H. Pylori Ure I].

Construction of prokaryotic expression system of ureB gene from a clinical isolate of Helicobacter pylori and identification of immunogenicity of the fusion protein

Construction of Prokaryotic Expression System of Ltb-Ureb Fusion Gene and Identification of the Recombinant Protein Immunity and Adjuvanticity

Construction of Expression Systems for Flaa and Flab Genes of Helicobacter Pylori and Determination of Immunoreactivity and Antigenicity of Recombinant Proteins.

Expression of the C-terminal 26 kDa fragment of Helicobacter pylori UreB in Escherichia coli and its immunity

Construction of Prokaryotic Expression System of Ureb Gene from a Clinical Helicobacter Pylori Strain and Identification of the Recombinant Protein Immunity.

Construction of prokaryotic expression system of<i>ureB</i>gene from a clinical<i>Helicobacter pylori</i>strain and identification of the recombinant protein immunity

Identification and Immunoprotective Effect of Prokaryotic Expression Product of Ltb-Hpaa Fusion Gene

Design based on Bioinformatics and Expression Optimization of Fusion Protein with Cholera Toxin B Subunit and an Epitope Peptide from Helicobacter pylori Urease A Subunit

Construction of Hpaa Gene from A Clinical Isolate of Helicobacter Pylori and Identification of Fusion Protein

Cloning and Expression of Fragment with 2148 Bp from Caga Gene from Isolates of a Helicobacter Pylori and Identification of Immunogenicity of the Recombinant Proteins

Immunoprotection of Recombinant Antigen LTB-UreB-HpaA in Helicobacter Pylori Infected Mice and Immunoenhancement of the Inner Adjuvant LTB

Expression of fusion protein CTB-mST2 in E. Coli and its bioactivity assay

Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit

Construction of Prokaryotic Expression System of 2 148-Bp Fragment from Caga Gene and Detection of Caga Gene, Caga Protein in Helicobacter Pylori Isolates and Its Antibody in Sera of Patients

Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model

[Construction and Expression of the Fusion Gene CCK39/UreB in Recombinant Escherichia Coli BL-21(DE3)].

Expression of CTB-p277 Fusion Gene in E. Coli and Analysis of ITS Immunogenecity

[Immunoprotective Effects of Helicobacter Pylori UreB and HpaA Bivalence Recombinant Vaccine with Inner Adjuvant on Experimental Infection in Mice].

Immunogenicity Characterization of the Multi-Epitope Vaccine CTB-UE with Chitosan-Cpg As Combination Adjuvants Against Helicobacter Pylori.

[Cloning of Urei Gene from Helicobacter Pylori and Its Expression in E. Coli].